Stryker Other Operating Income or Expenses 2010-2025 | SYK

Stryker annual/quarterly other operating income or expenses history and growth rate from 2010 to 2025. Other operating income or expenses can be defined as the aggregate amount of all operating expenses either too small to report separately or that cannot be standardized into another Zacks field.
  • Stryker other operating income or expenses for the quarter ending March 31, 2025 were $-35M, a 1066.67% increase year-over-year.
  • Stryker other operating income or expenses for the twelve months ending March 31, 2025 were $-1.009B, a 33533.33% increase year-over-year.
  • Stryker annual other operating income or expenses for 2024 were $-0.977B, a 2613.89% increase from 2023.
  • Stryker annual other operating income or expenses for 2023 were $-0.036B, a 86.67% decline from 2022.
  • Stryker annual other operating income or expenses for 2022 were $-0.27B, a 162.14% increase from 2021.
Stryker Annual Other Operating Income or Expenses
(Millions of US $)
2024 $-977
2023 $-36
2022 $-270
2021 $-103
2020 $-17
2019 $-192
2018 $-23
2017 $-173
2016 $-158
2015 $-296
2014 $-761
2013 $-760
2012 $-174
2011 $-122
2010 $-182
2009 $0
Stryker Quarterly Other Operating Income or Expenses
(Millions of US $)
2025-03-31 $-35
2024-12-31 $-974
2024-09-30
2024-06-30
2024-03-31 $-3
2023-12-31
2023-09-30
2023-06-30
2023-03-31
2022-12-31 $-256
2022-09-30 $4
2022-06-30 $-4
2022-03-31 $-14
2021-12-31 $-5
2021-09-30 $-16
2021-06-30 $-76
2021-03-31 $-6
2020-12-31 $-21
2020-09-30 $-2
2020-06-30
2020-03-31 $6
2019-12-31 $-13
2019-09-30 $-49
2019-06-30 $-117
2019-03-31 $-13
2018-12-31 $-13
2018-09-30 $-4
2018-06-30 $-2
2018-03-31 $-4
2017-12-31 $-9
2017-09-30 $-66
2017-06-30 $-72
2017-03-31 $-26
2016-12-31 $-54
2016-09-30 $-57
2016-06-30 $-28
2016-03-31 $-19
2015-12-31 $118
2015-09-30 $-150
2015-06-30 $-161
2015-03-31 $-103
2014-12-31 $-17
2014-09-30 $-79
2014-06-30 $-276
2014-03-31 $-389
2013-12-31
2013-09-30
2013-06-30
2013-03-31
2012-12-31 $-143
2012-09-30
2012-06-30 $-31
2012-03-31
2011-12-31 $-91
2011-09-30 $-31
2011-06-30
2011-03-31
2010-12-31
2010-09-30
2010-06-30
2010-03-31
2009-12-31 $9
2009-09-30 $-9
2009-06-30
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $144.385B $22.595B
Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $228.788B 27.51
Boston Scientific (BSX) United States $154.602B 38.70
EssilorLuxottica (ESLOY) France $135.514B 0.00
Medtronic (MDT) Ireland $103.771B 14.71
Haleon (HLN) United Kingdom $49.845B 28.36
Lonza Group Ag (LZAGY) Switzerland $48.977B 0.00
ResMed (RMD) United States $35.996B 27.04
GE HealthCare Technologies (GEHC) United States $31.796B 15.10
Agilent Technologies (A) United States $31.270B 20.66
Terumo (TRUMY) Japan $27.864B 36.19
Insulet (PODD) United States $22.590B 88.67
Koninklijke Philips (PHG) Netherlands $21.684B 15.59
Zimmer Biomet Holdings (ZBH) United States $18.137B 11.65
Baxter (BAX) United States $15.534B 11.60
Smith & Nephew SNATS (SNN) United Kingdom $12.438B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.181B 21.51
Lantheus Holdings (LNTH) United States $5.172B 13.05
Prestige Consumer Healthcare (PBH) United States $4.201B 18.77
Perrigo (PRGO) Ireland $3.629B 9.20
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.218B 23.73
Haemonetics (HAE) United States $3.178B 14.48
Envista Holdings (NVST) United States $2.859B 23.76
GN Store Nord (GNNDY) Denmark $2.097B 17.37
QuidelOrtho (QDEL) United States $2.041B 14.04
LeMaitre Vascular (LMAT) United States $1.788B 39.96
AtriCure (ATRC) United States $1.624B 0.00
Neogen (NEOG) United States $1.343B 17.19
Acuren (TIC) United States $1.288B 0.00
AdaptHealth (AHCO) United States $1.206B 12.25
Green Thumb Industries (GTBIF) United States $1.175B 26.43
Kestra Medical Technologies (KMTS) United States $1.145B 0.00
BioLife Solutions (BLFS) United States $1.050B 0.00
Phibro Animal Health (PAHC) United States $0.933B 11.93
InMode (INMD) Israel $0.906B 9.13
CeriBell (CBLL) United States $0.624B 0.00
Evolus (EOLS) United States $0.616B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.584B 0.00
Curaleaf Holdings (CURLF) Canada $0.558B 0.00
Owens & Minor (OMI) United States $0.532B 4.41
Valneva SE (VALN) France $0.529B 0.00
Capricor Therapeutics (CAPR) United States $0.496B 0.00
Tilray Brands (TLRY) Canada $0.450B 0.00
Surmodics (SRDX) United States $0.417B 0.00
Canopy Growth (CGC) Canada $0.355B 0.00
SNDL (SNDL) Canada $0.344B 0.00
Cresco Labs (CRLBF) United States $0.336B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.329B 0.00
VAREX IMAGING (VREX) United States $0.318B 11.71
Aurora Cannabis (ACB) Canada $0.309B 54.90
Sanara MedTech (SMTI) United States $0.275B 0.00
Viemed Healthcare (VMD) United States $0.258B 21.73
Sanuwave Health (SNWV) United States $0.247B 0.00
Verano Holdings (VRNOF) United States $0.244B 0.00
Cerus (CERS) United States $0.239B 0.00
ZimVie (ZIMV) United States $0.233B 10.57
Biote (BTMD) United States $0.205B 5.77
Brainsway (BWAY) Israel $0.197B 52.15
OraSure Technologies (OSUR) United States $0.192B 0.00
High Tide (HITI) Canada $0.189B 0.00
Omeros (OMER) United States $0.189B 0.00
Quanterix (QTRX) United States $0.188B 0.00
Organigram Global (OGI) Canada $0.183B 0.00
Utah Medical Products (UTMD) United States $0.174B 14.20
TriSalus Life Sciences (TLSI) United States $0.173B 0.00
FitLife Brands (FTLF) United States $0.131B 16.18
Exagen (XGN) United States $0.128B 0.00
Jin Medical (ZJYL) China $0.124B 0.00
TerrAscend (TSNDF) Canada $0.117B 0.00
Agape ATP (ATPC) $0.112B 0.00
MacroGenics (MGNX) United States $0.100B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.088B 0.00
Fonar (FONR) United States $0.087B 11.17
Quipt Home Medical (QIPT) United States $0.075B 0.00
Veru (VERU) United States $0.072B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.070B 0.00
Jushi Holdings (JUSHF) United States $0.064B 0.00
Apyx Medical (APYX) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.056B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
United Health Products (UEEC) United States $0.051B 0.00
Modular Medical (MODD) United States $0.045B 0.00
United-Guardian (UG) United States $0.037B 12.94
Rockwell Medical (RMTI) United States $0.034B 0.00
Safety Shot (SHOT) United States $0.028B 0.00
Nephros (NEPH) United States $0.028B 37.57
Allurion Technologies (ALUR) United States $0.022B 0.00
INLIF (INLF) $0.018B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
Trinity Biotech (TRIB) Ireland $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.010B 0.00
Innovative Eyewear (LUCY) United States $0.009B 0.00
Senestech (SNES) United States $0.005B 0.00
IM Cannabis (IMCC) Canada $0.004B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00